Anas Younes
MD
Chief, Lymphoma Service
👥Biography 个人简介
Anas Younes at MSK has contributed to lymphoma research including development of brentuximab vedotin (anti-CD30 ADC) for relapsed Hodgkin lymphoma and anaplastic large cell lymphoma, and to trials incorporating brentuximab into frontline Hodgkin therapy (ECHELON-1). He has also contributed to PD-1 checkpoint inhibitor development in Hodgkin lymphoma — a particularly sensitive cancer due to 9p24.1 amplification that increases PD-L1 expression.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Anas Younes 的研究动态
Follow Anas Younes's research updates
留下邮箱，当我们发布与 Anas Younes（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment